Search For "biopharmaceutical major biocon"
Tata Capital to pick minority stake in Biocon Biologics for Rs 225 cr
Updated : 5 years, 7 months ago IST
Bengaluru (Karnataka) [India], July 31 (ANI): Private equity major Tata Capital Growth Fund will pick up 0.85 per cent stake in the biologics arm of biopharmaceutical major Biocon for Rs 225 crore.
Read More
Biocon's drug Itolizumab gets DCGI nod for use in moderate to severe Covid
Updated : 5 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 11 (ANI): Biopharmaceutical major Biocon Ltd said on Saturday it has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5ml solution for emergency use in India for the treatment of cytokine release syndr
Read More
Biocon, DKSH collaborate to commercialise 7 generic formulations in SE Asi
Updated : 5 years, 9 months ago IST
Bengaluru (Karnataka) [India], June 22 (ANI): Biopharmaceutical major Biocon Ltd and Swiss market expansion services group Diethelm Keller Siber Hegner (DKSH) said on Monday their subsidiaries have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic
Read More
Biocon expands footprint to Chinese pharmaceuticals market with generic fo
Updated : 6 years, 6 months ago IST
Bengaluru (Karnataka) [India], Sep 13 (ANI): Biopharmaceutical major Biocon has signed a license and supply agreement with a subsidiary of China Medical System (CMS) Holdings Ltd for three generic formulation products in Greater China.
Read More
European drug regulator approves Biocon's Malaysia insulin facility
Updated : 6 years, 7 months ago IST
Bengaluru (Karnataka) [India], Aug 22 (ANI): Biopharmaceutical major Biocon said on Thursday said its insulin facility in Malaysia has been approved by the European Medicines Agency.
Read More
Biocon Q1 net profit gallops 72 pc to Rs 206 crore
Updated : 6 years, 8 months ago IST
Bengaluru (Karnataka) [India], July 26 (ANI): Biopharmaceutical major Biocon has reported 72 per cent jump in its consolidated net profit at Rs 206 crore during the quarter ended June 30 as opposed to Rs 120 crore during the corresponding quarter last fiscal.
Read More